Global Semisolid Dosage Form Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Semisolid Dosage Form Consumption Value by Type: 2020 Versus 2024 Versus 2031
  • 1.3.2 Ointments
  • 1.3.3 Pastes
  • 1.3.4 Plasters
  • 1.3.5 Gels
  • 1.3.6 Rigid Foams
• 1.4 Market Analysis by Application
  • 1.4.1 Overview: Global Semisolid Dosage Form Consumption Value by Application: 2020 Versus 2024 Versus 2031
  • 1.4.2 Skin
  • 1.4.3 Nasal Cavity
  • 1.4.4 Vaginal Cavity
  • 1.4.5 Rectal Cavity
  • 1.4.6 Others
• 1.5 Global Semisolid Dosage Form Market Size & Forecast
  • 1.5.1 Global Semisolid Dosage Form Consumption Value (2020 & 2024 & 2031)
  • 1.5.2 Global Semisolid Dosage Form Sales Quantity (2020-2031)
  • 1.5.3 Global Semisolid Dosage Form Average Price (2020-2031)

2 Manufacturers Profiles

• 2.1 Johnson & Johnson
  • 2.1.1 Johnson & Johnson Details
  • 2.1.2 Johnson & Johnson Major Business
  • 2.1.3 Johnson & Johnson Semisolid Dosage Form Product and Services
  • 2.1.4 Johnson & Johnson Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.1.5 Johnson & Johnson Recent Developments/Updates
• 2.2 Merck & Co
  • 2.2.1 Merck & Co Details
  • 2.2.2 Merck & Co Major Business
  • 2.2.3 Merck & Co Semisolid Dosage Form Product and Services
  • 2.2.4 Merck & Co Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.2.5 Merck & Co Recent Developments/Updates
• 2.3 Bayer AG
  • 2.3.1 Bayer AG Details
  • 2.3.2 Bayer AG Major Business
  • 2.3.3 Bayer AG Semisolid Dosage Form Product and Services
  • 2.3.4 Bayer AG Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.3.5 Bayer AG Recent Developments/Updates
• 2.4 Hisamitsu Pharmaceutical
  • 2.4.1 Hisamitsu Pharmaceutical Details
  • 2.4.2 Hisamitsu Pharmaceutical Major Business
  • 2.4.3 Hisamitsu Pharmaceutical Semisolid Dosage Form Product and Services
  • 2.4.4 Hisamitsu Pharmaceutical Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.4.5 Hisamitsu Pharmaceutical Recent Developments/Updates
• 2.5 Glenmark Pharmaceuticals
  • 2.5.1 Glenmark Pharmaceuticals Details
  • 2.5.2 Glenmark Pharmaceuticals Major Business
  • 2.5.3 Glenmark Pharmaceuticals Semisolid Dosage Form Product and Services
  • 2.5.4 Glenmark Pharmaceuticals Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.5.5 Glenmark Pharmaceuticals Recent Developments/Updates
• 2.6 Cipla Ltd
  • 2.6.1 Cipla Ltd Details
  • 2.6.2 Cipla Ltd Major Business
  • 2.6.3 Cipla Ltd Semisolid Dosage Form Product and Services
  • 2.6.4 Cipla Ltd Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.6.5 Cipla Ltd Recent Developments/Updates
• 2.7 Nestlé SA
  • 2.7.1 Nestlé SA Details
  • 2.7.2 Nestlé SA Major Business
  • 2.7.3 Nestlé SA Semisolid Dosage Form Product and Services
  • 2.7.4 Nestlé SA Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.7.5 Nestlé SA Recent Developments/Updates
• 2.8 Novartis AG
  • 2.8.1 Novartis AG Details
  • 2.8.2 Novartis AG Major Business
  • 2.8.3 Novartis AG Semisolid Dosage Form Product and Services
  • 2.8.4 Novartis AG Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.8.5 Novartis AG Recent Developments/Updates
• 2.9 GlaxoSmithKline plc
  • 2.9.1 GlaxoSmithKline plc Details
  • 2.9.2 GlaxoSmithKline plc Major Business
  • 2.9.3 GlaxoSmithKline plc Semisolid Dosage Form Product and Services
  • 2.9.4 GlaxoSmithKline plc Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.9.5 GlaxoSmithKline plc Recent Developments/Updates
• 2.10 Bausch Health Companies
  • 2.10.1 Bausch Health Companies Details
  • 2.10.2 Bausch Health Companies Major Business
  • 2.10.3 Bausch Health Companies Semisolid Dosage Form Product and Services
  • 2.10.4 Bausch Health Companies Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.10.5 Bausch Health Companies Recent Developments/Updates
• 2.11 Allergan
  • 2.11.1 Allergan Details
  • 2.11.2 Allergan Major Business
  • 2.11.3 Allergan Semisolid Dosage Form Product and Services
  • 2.11.4 Allergan Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.11.5 Allergan Recent Developments/Updates
• 2.12 Biofrontera, Inc.
  • 2.12.1 Biofrontera, Inc. Details
  • 2.12.2 Biofrontera, Inc. Major Business
  • 2.12.3 Biofrontera, Inc. Semisolid Dosage Form Product and Services
  • 2.12.4 Biofrontera, Inc. Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.12.5 Biofrontera, Inc. Recent Developments/Updates
• 2.13 Crown Laboratories Inc.
  • 2.13.1 Crown Laboratories Inc. Details
  • 2.13.2 Crown Laboratories Inc. Major Business
  • 2.13.3 Crown Laboratories Inc. Semisolid Dosage Form Product and Services
  • 2.13.4 Crown Laboratories Inc. Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.13.5 Crown Laboratories Inc. Recent Developments/Updates
• 2.14 Akorn Inc. (US)
  • 2.14.1 Akorn Inc. (US) Details
  • 2.14.2 Akorn Inc. (US) Major Business
  • 2.14.3 Akorn Inc. (US) Semisolid Dosage Form Product and Services
  • 2.14.4 Akorn Inc. (US) Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.14.5 Akorn Inc. (US) Recent Developments/Updates
• 2.15 Ingenus Pharmaceuticals
  • 2.15.1 Ingenus Pharmaceuticals Details
  • 2.15.2 Ingenus Pharmaceuticals Major Business
  • 2.15.3 Ingenus Pharmaceuticals Semisolid Dosage Form Product and Services
  • 2.15.4 Ingenus Pharmaceuticals Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.15.5 Ingenus Pharmaceuticals Recent Developments/Updates
• 2.16 Sun Pharmaceuticals
  • 2.16.1 Sun Pharmaceuticals Details
  • 2.16.2 Sun Pharmaceuticals Major Business
  • 2.16.3 Sun Pharmaceuticals Semisolid Dosage Form Product and Services
  • 2.16.4 Sun Pharmaceuticals Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.16.5 Sun Pharmaceuticals Recent Developments/Updates
• 2.17 Crescita Therapeutics Inc.
  • 2.17.1 Crescita Therapeutics Inc. Details
  • 2.17.2 Crescita Therapeutics Inc. Major Business
  • 2.17.3 Crescita Therapeutics Inc. Semisolid Dosage Form Product and Services
  • 2.17.4 Crescita Therapeutics Inc. Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.17.5 Crescita Therapeutics Inc. Recent Developments/Updates
• 2.18 Mylan N.V.
  • 2.18.1 Mylan N.V. Details
  • 2.18.2 Mylan N.V. Major Business
  • 2.18.3 Mylan N.V. Semisolid Dosage Form Product and Services
  • 2.18.4 Mylan N.V. Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.18.5 Mylan N.V. Recent Developments/Updates
• 2.19 Encore Dermatology, Inc.
  • 2.19.1 Encore Dermatology, Inc. Details
  • 2.19.2 Encore Dermatology, Inc. Major Business
  • 2.19.3 Encore Dermatology, Inc. Semisolid Dosage Form Product and Services
  • 2.19.4 Encore Dermatology, Inc. Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.19.5 Encore Dermatology, Inc. Recent Developments/Updates
• 2.20 LEO Pharma
  • 2.20.1 LEO Pharma Details
  • 2.20.2 LEO Pharma Major Business
  • 2.20.3 LEO Pharma Semisolid Dosage Form Product and Services
  • 2.20.4 LEO Pharma Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.20.5 LEO Pharma Recent Developments/Updates
• 2.21 Almirall, S.A
  • 2.21.1 Almirall, S.A Details
  • 2.21.2 Almirall, S.A Major Business
  • 2.21.3 Almirall, S.A Semisolid Dosage Form Product and Services
  • 2.21.4 Almirall, S.A Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.21.5 Almirall, S.A Recent Developments/Updates
• 2.22 Aclaris Therapeutics, Inc.
  • 2.22.1 Aclaris Therapeutics, Inc. Details
  • 2.22.2 Aclaris Therapeutics, Inc. Major Business
  • 2.22.3 Aclaris Therapeutics, Inc. Semisolid Dosage Form Product and Services
  • 2.22.4 Aclaris Therapeutics, Inc. Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.22.5 Aclaris Therapeutics, Inc. Recent Developments/Updates
• 2.23 Taro Pharmaceutical Industries Ltd.
  • 2.23.1 Taro Pharmaceutical Industries Ltd. Details
  • 2.23.2 Taro Pharmaceutical Industries Ltd. Major Business
  • 2.23.3 Taro Pharmaceutical Industries Ltd. Semisolid Dosage Form Product and Services
  • 2.23.4 Taro Pharmaceutical Industries Ltd. Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.23.5 Taro Pharmaceutical Industries Ltd. Recent Developments/Updates
• 2.24 Teligent Pharma
  • 2.24.1 Teligent Pharma Details
  • 2.24.2 Teligent Pharma Major Business
  • 2.24.3 Teligent Pharma Semisolid Dosage Form Product and Services
  • 2.24.4 Teligent Pharma Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.24.5 Teligent Pharma Recent Developments/Updates
• 2.25 Perrigo Pharma
  • 2.25.1 Perrigo Pharma Details
  • 2.25.2 Perrigo Pharma Major Business
  • 2.25.3 Perrigo Pharma Semisolid Dosage Form Product and Services
  • 2.25.4 Perrigo Pharma Semisolid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.25.5 Perrigo Pharma Recent Developments/Updates

3 Competitive Environment: Semisolid Dosage Form by Manufacturer

• 3.1 Global Semisolid Dosage Form Sales Quantity by Manufacturer (2020-2025)
• 3.2 Global Semisolid Dosage Form Revenue by Manufacturer (2020-2025)
• 3.3 Global Semisolid Dosage Form Average Price by Manufacturer (2020-2025)
• 3.4 Market Share Analysis (2024)
  • 3.4.1 Producer Shipments of Semisolid Dosage Form by Manufacturer Revenue ($MM) and Market Share (%): 2024
  • 3.4.2 Top 3 Semisolid Dosage Form Manufacturer Market Share in 2024
  • 3.4.3 Top 6 Semisolid Dosage Form Manufacturer Market Share in 2024
• 3.5 Semisolid Dosage Form Market: Overall Company Footprint Analysis
  • 3.5.1 Semisolid Dosage Form Market: Region Footprint
  • 3.5.2 Semisolid Dosage Form Market: Company Product Type Footprint
  • 3.5.3 Semisolid Dosage Form Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Semisolid Dosage Form Market Size by Region
  • 4.1.1 Global Semisolid Dosage Form Sales Quantity by Region (2020-2031)
  • 4.1.2 Global Semisolid Dosage Form Consumption Value by Region (2020-2031)
  • 4.1.3 Global Semisolid Dosage Form Average Price by Region (2020-2031)
• 4.2 North America Semisolid Dosage Form Consumption Value (2020-2031)
• 4.3 Europe Semisolid Dosage Form Consumption Value (2020-2031)
• 4.4 Asia-Pacific Semisolid Dosage Form Consumption Value (2020-2031)
• 4.5 South America Semisolid Dosage Form Consumption Value (2020-2031)
• 4.6 Middle East & Africa Semisolid Dosage Form Consumption Value (2020-2031)

5 Market Segment by Type

• 5.1 Global Semisolid Dosage Form Sales Quantity by Type (2020-2031)
• 5.2 Global Semisolid Dosage Form Consumption Value by Type (2020-2031)
• 5.3 Global Semisolid Dosage Form Average Price by Type (2020-2031)

6 Market Segment by Application

• 6.1 Global Semisolid Dosage Form Sales Quantity by Application (2020-2031)
• 6.2 Global Semisolid Dosage Form Consumption Value by Application (2020-2031)
• 6.3 Global Semisolid Dosage Form Average Price by Application (2020-2031)

7 North America

• 7.1 North America Semisolid Dosage Form Sales Quantity by Type (2020-2031)
• 7.2 North America Semisolid Dosage Form Sales Quantity by Application (2020-2031)
• 7.3 North America Semisolid Dosage Form Market Size by Country
  • 7.3.1 North America Semisolid Dosage Form Sales Quantity by Country (2020-2031)
  • 7.3.2 North America Semisolid Dosage Form Consumption Value by Country (2020-2031)
  • 7.3.3 United States Market Size and Forecast (2020-2031)
  • 7.3.4 Canada Market Size and Forecast (2020-2031)
  • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

• 8.1 Europe Semisolid Dosage Form Sales Quantity by Type (2020-2031)
• 8.2 Europe Semisolid Dosage Form Sales Quantity by Application (2020-2031)
• 8.3 Europe Semisolid Dosage Form Market Size by Country
  • 8.3.1 Europe Semisolid Dosage Form Sales Quantity by Country (2020-2031)
  • 8.3.2 Europe Semisolid Dosage Form Consumption Value by Country (2020-2031)
  • 8.3.3 Germany Market Size and Forecast (2020-2031)
  • 8.3.4 France Market Size and Forecast (2020-2031)
  • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
  • 8.3.6 Russia Market Size and Forecast (2020-2031)
  • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

• 9.1 Asia-Pacific Semisolid Dosage Form Sales Quantity by Type (2020-2031)
• 9.2 Asia-Pacific Semisolid Dosage Form Sales Quantity by Application (2020-2031)
• 9.3 Asia-Pacific Semisolid Dosage Form Market Size by Region
  • 9.3.1 Asia-Pacific Semisolid Dosage Form Sales Quantity by Region (2020-2031)
  • 9.3.2 Asia-Pacific Semisolid Dosage Form Consumption Value by Region (2020-2031)
  • 9.3.3 China Market Size and Forecast (2020-2031)
  • 9.3.4 Japan Market Size and Forecast (2020-2031)
  • 9.3.5 South Korea Market Size and Forecast (2020-2031)
  • 9.3.6 India Market Size and Forecast (2020-2031)
  • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
  • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

• 10.1 South America Semisolid Dosage Form Sales Quantity by Type (2020-2031)
• 10.2 South America Semisolid Dosage Form Sales Quantity by Application (2020-2031)
• 10.3 South America Semisolid Dosage Form Market Size by Country
  • 10.3.1 South America Semisolid Dosage Form Sales Quantity by Country (2020-2031)
  • 10.3.2 South America Semisolid Dosage Form Consumption Value by Country (2020-2031)
  • 10.3.3 Brazil Market Size and Forecast (2020-2031)
  • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

• 11.1 Middle East & Africa Semisolid Dosage Form Sales Quantity by Type (2020-2031)
• 11.2 Middle East & Africa Semisolid Dosage Form Sales Quantity by Application (2020-2031)
• 11.3 Middle East & Africa Semisolid Dosage Form Market Size by Country
  • 11.3.1 Middle East & Africa Semisolid Dosage Form Sales Quantity by Country (2020-2031)
  • 11.3.2 Middle East & Africa Semisolid Dosage Form Consumption Value by Country (2020-2031)
  • 11.3.3 Turkey Market Size and Forecast (2020-2031)
  • 11.3.4 Egypt Market Size and Forecast (2020-2031)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
  • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

• 12.1 Semisolid Dosage Form Market Drivers
• 12.2 Semisolid Dosage Form Market Restraints
• 12.3 Semisolid Dosage Form Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Semisolid Dosage Form and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Semisolid Dosage Form
• 13.3 Semisolid Dosage Form Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Semisolid Dosage Form Typical Distributors
• 14.3 Semisolid Dosage Form Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source